PUBLISHER: The Insight Partners | PRODUCT CODE: 2166029
PUBLISHER: The Insight Partners | PRODUCT CODE: 2166029
The South and Central America Negative Pressure Wound Therapy (NPWT) Market is projected to rise from US$ 143.9 Million in 2025 to US$ 249.4 Million by 2034, registering an estimated CAGR of 6.5% from 2026 to 2034.
Executive Summary and South and Central America Negative Pressure Wound Therapy (NPWT) Market Analysis
The South and Central America NPWT market is divided into Brazil, Argentina, and the Rest of South & Central America. Adoption remains moderate but is steadily increasing as the region experiences a growing burden of chronic wounds and improvements in healthcare accessibility. Brazil and Argentina represent important markets, supported by expanding medical infrastructure, increasing surgical activity, and a rising prevalence of diabetes and other chronic conditions.
Private healthcare facilities are currently at the forefront of incorporating advanced wound-management technologies. The development of modern hospitals, specialized wound-care centers, and outpatient facilities is creating new opportunities for NPWT systems. Healthcare providers are increasingly interested in portable technologies that can be used for postoperative wounds and chronic conditions in both institutional and homecare environments.
Public-sector programs and private investment are contributing to improvements in healthcare infrastructure and encouraging the adoption of contemporary wound-care practices. Brazil, in particular, is increasing its use of NPWT to support postoperative recovery and manage complex wounds associated with chronic disease.
Greater awareness among healthcare professionals regarding the clinical advantages of NPWT is also supporting market development. Improvements in reimbursement mechanisms, although inconsistent between countries, are gradually making advanced wound-care technologies more accessible.
Leading companies such as Convatec and Cardinal Health are strengthening their presence through strategic initiatives, distribution expansion, and product development. NPWT is increasingly being considered for conditions including diabetic foot ulcers, pressure injuries, venous leg ulcers, and postoperative wounds.
The growing prevalence of diabetes and traumatic injuries across emerging markets presents additional opportunities. At the same time, the global movement toward outpatient and home-based treatment is encouraging regional healthcare providers to explore portable NPWT solutions that can reduce hospital dependence while maintaining effective wound management.
Strategic Insights
South and Central America Negative Pressure Wound Therapy (NPWT) Market Segmentation Analysis
By Product: The market is segmented into Conventional NPWT Devices, Single-use NPWT Devices, and NPWT Accessories. Conventional NPWT Devices held the largest market share in 2025.
By Wound Type: The market is categorized into Chronic Wounds and Acute Wounds. Chronic Wounds represented the dominant segment in 2025.
By Chronic Wounds - Type: Segmentation includes Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, and Other Chronic Wounds. Diabetic Foot Ulcers accounted for the leading share in 2025.
By Acute Wounds - Type: The market comprises Surgical and Traumatic Wounds and Burns. Surgical and Traumatic Wounds dominated the segment in 2025.
By End User: The market is divided into Hospitals, Specialty Clinics, Homecare Settings, and Others. Hospitals remained the largest end-user segment in 2025.
Market Report Scope
South and Central America Negative Pressure Wound Therapy (NPWT) Market Outlook
One of the most significant opportunities for the regional NPWT market is the expansion of home-based wound care combined with telemedicine and remote monitoring. This approach can improve access to treatment, reduce pressure on hospitals, and allow clinicians to identify wound complications at an earlier stage.
Home-based NPWT is particularly relevant for patients with chronic wounds, older individuals, and people with multiple comorbidities who may experience difficulties with repeated hospital visits. Telemedicine enables healthcare professionals to monitor wound progress remotely, provide treatment guidance, and intervene when healing does not progress as expected.
Evidence from diabetic foot ulcer management indicates that telemedicine can provide meaningful economic and clinical benefits. One analysis reported savings of approximately US$ 2,222 per patient compared with conventional in-person care, alongside a 41.6% reduction in wound area and patient satisfaction of approximately 94%.
Remote therapeutic monitoring can also generate cost advantages for NPWT patients. Research has reported wound-related costs of approximately US$ 11,119 per patient among individuals receiving remote monitoring, compared with US$ 14,752 for those without monitoring. These findings are particularly relevant for healthcare systems seeking to reduce the financial burden associated with prolonged wound treatment.
Community-based NPWT represents another promising opportunity. Studies have indicated potential savings of approximately US$ 6,496 per patient compared with inpatient management, accompanied by reductions in hospitalization, wound-related complications, and emergency admissions.
The increased adoption of telehealth following the COVID-19 pandemic has further established remote healthcare as an important component of modern clinical practice. Integrating NPWT with digital monitoring can allow patients to remain at home while healthcare teams track wound progression and treatment adherence.
For South and Central America, these technologies may be particularly valuable in geographically remote areas where specialist wound-care services are not readily available. Portable NPWT systems supported by telemedicine could extend advanced treatment beyond major urban hospitals, improve continuity of care, and reduce unnecessary hospital readmissions.
South and Central America Negative Pressure Wound Therapy (NPWT) Market Country Insights
The market is segmented into Brazil, Argentina, and the Rest of South and Central America, with Brazil accounting for the largest share in 2025.
Brazil's NPWT market is benefiting from comparatively developed healthcare infrastructure and increasing attention to chronic diseases, particularly diabetes. Approximately 15.7 million Brazilian adults are affected by diabetes, contributing to the prevalence of diabetic foot ulcers and other difficult-to-heal wounds.
Public and private healthcare investments have enabled greater integration of NPWT across hospitals, specialist wound-care centers, and homecare programs. The technology is used to manage complex wounds such as pressure ulcers, surgical incisions, and diabetic ulcers by controlling exudate, supporting tissue formation, and helping reduce infection risks.
Brazilian healthcare providers are increasingly adopting portable and single-use NPWT systems. These products can improve patient mobility and make treatment more practical outside traditional hospital environments. The trend is particularly relevant to older patients, among whom chronic wounds can be compounded by obesity, cardiovascular disease, and other comorbidities.
National initiatives focused on diabetic foot management are also supporting greater use of advanced wound-care technologies. NPWT has applications in treating wounds associated with diabetes, musculoskeletal disorders, trauma, and postoperative complications. Clinicians have reported improved wound-management outcomes and potential reductions in hospital stays for selected patients with venous leg ulcers and other complex wounds.
Collaboration with international manufacturers is contributing to technological advancement. Companies such as Smith & Nephew and Medtronic are supporting the introduction of systems with improved portability and digital connectivity, allowing clinicians to monitor wound progress more efficiently.
Diabetes represents a substantial regional healthcare challenge. Data from the Pan American Health Organization indicate that more than 60 million people in Latin America live with diabetes, with Brazil carrying a significant portion of this burden. Consequently, demand for NPWT is expected to remain strong, particularly in postoperative and orthopedic applications where complex wounds require specialized management.
South and Central America Negative Pressure Wound Therapy (NPWT) Market Company Profiles
Major companies operating in the market include Cardinal Health Inc, Smith & Nephew Plc, Molnlycke Health Care AB, Coloplast AS, Carilex Medical, Genadyne Biotechnologies, Inc., Medela AG, Paul Hartmann AG, DeRoyal Industries Inc, Convatec Inc, Pensar Medical, Solventum Corporation, and MONDOMED.
These companies are pursuing strategies such as market expansion, product innovation, strategic partnerships, technological development, and mergers and acquisitions. Through these initiatives, market participants aim to broaden their product offerings, strengthen regional distribution networks, improve access to advanced wound-care solutions, and increase their market share.